Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05181800
What this trial is testing

FIRMAGON® Intensive Drug Monitoring

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 1,454
Testing effectiveness (Phase 2)Study completedNCT05361031
What this trial is testing

The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)

Who this might be right for
CMT
Helixmith Co., Ltd. 12
Large-scale testing (Phase 3)Study completedNCT00002445
What this trial is testing

Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients

Who this might be right for
Sarcoma, KaposiHIV Infections
Cytran 200
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT05076253
What this trial is testing

Efficacy of Ivermectin in COVID-19

Who this might be right for
SafetySARS-CoV2 InfectionIvermectin Poisoning+1 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 72
Early research (Phase 1)Not Yet RecruitingNCT07572812
What this trial is testing

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Who this might be right for
Epilepsy
Shanghai UniXell Biotechnology Co., Ltd 12
Early research (Phase 1)Study completedNCT05155995
What this trial is testing

Evaluate the Pharmacokinetics and Safety Between HCP2001 and Co-administration of Each Component in Healthy Volunteers

Who this might be right for
Healthy
Hanmi Pharmaceutical Company Limited 71
Early research (Phase 1)Study completedNCT03482453
What this trial is testing

Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants

Who this might be right for
Healthy Volunteers
Millennium Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT02933502
What this trial is testing

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 3
Early research (Phase 1)Study completedNCT03610945
What this trial is testing

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT01096472
What this trial is testing

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Who this might be right for
Tinea Pedis
Almirall, S.A. 120
Early research (Phase 1)UnknownNCT05155839
What this trial is testing

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
Shanghai Miracogen Inc. 108
Large-scale testing (Phase 3)Study completedNCT00090246
What this trial is testing

2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)

Who this might be right for
Postoperative Nausea and Vomiting
Merck Sharp & Dohme LLC 922
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Early research (Phase 1)Study completedNCT05976373
What this trial is testing

Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.

Who this might be right for
Healthy Volunteers
Sanofi 38
Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986
Early research (Phase 1)Study completedNCT02846142
What this trial is testing

Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers

Who this might be right for
Healthy Volunteer
Proteostasis Therapeutics, Inc. 94
Not applicableLooking for participantsNCT06410313
What this trial is testing

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

Who this might be right for
Superficial Femoral Artery StenosisPopliteal Artery Stenosis
Medinol Ltd. 30
Early research (Phase 1)Study completedNCT01319903
What this trial is testing

Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29

Who this might be right for
Drug Safety
InflaRx GmbH 26
Not applicableEnded earlyNCT04269486
What this trial is testing

Observational Study on Safety of the Herbal Medicines at Inpatient Setting

Who this might be right for
Drug Induced Liver InjuryDrug-Induced Kidney InjuryHerbal Medicine Adverse Reaction
Korea Institute of Oriental Medicine 287
Next Page